Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing intermittent fasting and carbohydrate drinks before surgery

Official title: Preoperative Intermittent Fasting Versus Carbohydrate Loading to Reduce Insulin Resistance: a Randomised Controlled Trial

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT05760339 · Data updated 2026-11-12

This study is testing whether intermittent fasting or drinking carbohydrate drinks before surgery helps people with orthopedic issues have better metabolic health.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment75 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations1 site (Amsterdam, North Holland)
StatusRecruiting
StartedMarch 20, 2023
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedOctober 29, 2026
Trial IDNCT05760339 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults scheduled for elective orthopedic surgery who are motivated to adhere to a time-restricted feeding regimen.

Probably not a fit

Patients with a history of diabetes, eating disorders, or certain other medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of time-restricted feeding (intermittent fasting) versus carbohydrate loading on insulin resistance in patients undergoing orthopedic surgery. Participants in the time-restricted feeding group will follow an 8-hour eating window and a 16-hour fasting period for two weeks prior to surgery, while the carbohydrate loading group will consume a maltodextrin beverage before surgery. The goal is to determine which approach better improves metabolic outcomes around the time of surgery.

Why it matters

Potential benefit: If successful, this study could lead to improved metabolic health and recovery outcomes for patients undergoing orthopedic surgery.

How similar studies have gone: Other studies have shown promising results with intermittent fasting approaches, suggesting potential benefits in metabolic health, but this specific comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Undergoing elective orthopaedic surgery;
* Intermediate, major or complex surgery according to the Surgical Outcome Risk Tool (SORT; http://www.sortsurgery.com/) severity of surgery classification;
* Scheduled for surgery at least 17 days from the date of screening;
* Motivated to follow a time restricted feeding regimen.
* Willing and able to provide written informed consent.

Exclusion Criteria:

* History of diabetes mellitus;
* History of feeding or eating disorders;
* History of delayed gastric emptying or gastro-oesophageal reflux
* Active malignancy
* Patients classified as ASA IV by the attending anaesthetist;
* BMI \< 18.5 or ≥ 35;
* Outpatient or day case surgery;
* Palliative surgery;
* Participation in another clinical trial that is interfering with the procedures or outcomes of the PRINCESS trial;
* Patients unable to fully comply to study needs (e.g. legally incapable patients or patients unable to communicate in Dutch).

Where it's running

  • Amsterdam UMC location AMC
    Amsterdam, North Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.